Prognostic Value of Neutrophil-To-Lymphocyte Ratio Following Chemoradiation Therapy for Stage III Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.1684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Factors for Survival After Recurrence of Stage III Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Neutrophil-Lymphocyte Ratio Predicts Recurrence in Patients With Resected Stage 1 Non-Small Cell Lung Cancer

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2018English

Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non–Small Cell Lung Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

P1.17-08 Genetic Predictors of Response to Chemoradiation in Stage III Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Neutrophil to Lymphocyte Ratio (NLR) in Peripheral Blood: A Novel and Simple Prognostic Predictor of Non-Small Cell Lung Cancer (NSCLC)

2017English

Exploring the Prognostic Value of the Neutrophil-To-Lymphocyte Ratio in Cancer

Scientific Reports
Multidisciplinary
2019English

203P: Could Neutrophil-To-Lymphocyte Ratio Be Predictor of Brain Metastases in Non Small Cell Lung Cancer?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Plateletto- Lymphocyte Ratio in Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Oncotarget
Oncology
2018English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy